Large genomic datasets place TP53 alterations predominantly within MSS disease, co-occurring with chromosomal instability and WNT/MAPK pathway events; these molecular constellations align with transcriptomic taxonomies that capture epithelial/proliferative and mesenchymal-like states with distinct immune ecologies [30,31]. The gene discussed is TP53; the disease is Marinesco-Sjogren syndrome.